Page 2 - Johnc Jacobs News Today

GAITHERSBURG, Md., Jan. 3, 2024 /PRNewswire/ -- Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will participate in the 42th...

The R21/Matrix-M™ malaria vaccine is one step closer to mass rollout, after officially receiving WHO prequalification status, making it eligible for procurement by United Nations agencies.

Today 21st December 2023 the R21/Matrix-MTM malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, has been awarded prequalification status by the World Health Organization (W

Novavaxs updated vaccine will be available at vaccination centers across TaiwanGAITHERSBURG, Md., Dec. 18, 2023 /PRNewswire/ -- Novavax, Inc. , a global company advancing protein-based vaccines...

OTTAWA — Health Canada authorized Novavax's updated COVID-19 vaccine targeting the XBB.1.5 variant on Tuesday.

Novavax announces that Health Canada has granted extended authorization for the Nuvaxovid XBB.1.5 vaccine to prevent Covid-19 as early as age 12. The Public Health Agency of Canadas National Advisory...

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Health Canada...

OTTAWA - Health Canada authorized Novavax's updated COVID-19 vaccine targeting the XBB.1.5 variant on Tuesday.

Novavaxs updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming daysGAITHERSBURG, Md., Dec. 5, 2023 /PRNewswire/ -- Novavax,...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M(TM) adjuvant,today announced that Nuvaxovid(TM) XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) has been granted Emergency Use Listing (EUL) by the World Health